A detailed history of Ifp Advisors, Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 32,057 shares of ABBV stock, worth $5.62 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
32,057
Previous 29,910 7.18%
Holding current value
$5.62 Million
Previous $5.45 Million 0.95%
% of portfolio
0.23%
Previous 0.25%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$154.79 - $180.76 $332,334 - $388,091
2,147 Added 7.18%
32,057 $5.5 Million
Q1 2024

Jul 30, 2024

SELL
$159.82 - $182.1 $199,934 - $227,807
-1,251 Reduced 4.01%
29,910 $5.45 Million
Q4 2023

Jan 09, 2024

SELL
$137.6 - $154.97 $2.32 Million - $2.61 Million
-16,869 Reduced 35.12%
31,161 $4.83 Million
Q3 2023

Oct 12, 2023

BUY
$133.59 - $154.65 $173,533 - $200,890
1,299 Added 2.78%
48,030 $7.16 Million
Q2 2023

Aug 04, 2023

BUY
$132.51 - $164.9 $15,503 - $19,293
117 Added 0.25%
46,731 $6.3 Million
Q1 2023

Apr 18, 2023

SELL
$144.61 - $166.54 $2.93 Million - $3.38 Million
-20,283 Reduced 30.32%
46,614 $7.43 Million
Q4 2022

Feb 07, 2023

SELL
$138.31 - $165.87 $68,878 - $82,603
-498 Reduced 0.74%
66,897 $2.49 Million
Q3 2022

Nov 08, 2022

BUY
$134.21 - $153.93 $830,491 - $952,518
6,188 Added 10.11%
67,395 $2.52 Million
Q2 2022

Sep 06, 2022

BUY
$137.62 - $174.96 $8.42 Million - $10.7 Million
61,207 New
61,207 $2.29 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $8.42 Million - $10.7 Million
-61,207 Closed
0 $0
Q1 2022

Sep 06, 2022

BUY
$131.98 - $163.75 $2.25 Million - $2.79 Million
17,036 Added 38.57%
61,207 $9.92 Million
Q1 2022

Aug 08, 2022

BUY
$131.98 - $163.75 $90,802 - $112,660
688 Added 1.58%
44,171 $7.16 Million
Q4 2021

Jan 12, 2022

SELL
$107.43 - $135.93 $143,419 - $181,466
-1,335 Reduced 2.98%
43,483 $5.89 Million
Q3 2021

Oct 06, 2021

BUY
$106.4 - $120.78 $619,248 - $702,939
5,820 Added 14.92%
44,818 $4.85 Million
Q2 2021

Jul 13, 2021

BUY
$105.21 - $117.21 $249,137 - $277,553
2,368 Added 6.46%
38,998 $4.39 Million
Q1 2021

Apr 30, 2021

SELL
$102.3 - $112.62 $29,564 - $32,547
-289 Reduced 0.78%
36,630 $3.97 Million
Q4 2020

Jan 25, 2021

BUY
$80.49 - $108.67 $207,825 - $280,585
2,582 Added 7.52%
36,919 $3.96 Million
Q3 2020

Oct 29, 2020

BUY
$85.91 - $100.83 $373,880 - $438,812
4,352 Added 14.51%
34,337 $3.01 Million
Q2 2020

Aug 05, 2020

BUY
$73.37 - $98.18 $366,996 - $491,096
5,002 Added 20.02%
29,985 $2.89 Million
Q1 2020

May 12, 2020

BUY
$64.5 - $97.79 $29,928 - $45,374
464 Added 1.89%
24,983 $1.85 Million
Q4 2019

Jan 17, 2020

BUY
$72.13 - $90.25 $4,832 - $6,046
67 Added 0.27%
24,519 $2.19 Million
Q3 2019

Nov 07, 2019

BUY
$62.98 - $75.72 $937,394 - $1.13 Million
14,884 Added 155.56%
24,452 $1.82 Million
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $3.22 Million - $3.79 Million
-41,783 Reduced 81.37%
9,568 $767,000
Q4 2018

Jan 23, 2019

SELL
$77.85 - $96.01 $1.05 Million - $1.29 Million
-13,473 Reduced 20.78%
51,351 $4.73 Million
Q3 2018

Oct 25, 2018

BUY
$88.91 - $98.84 $217,473 - $241,762
2,446 Added 3.92%
64,824 $0
Q2 2018

Aug 07, 2018

SELL
$89.78 - $106.23 $1.29 Million - $1.52 Million
-14,344 Reduced 18.7%
62,378 $0
Q1 2018

Jun 03, 2019

BUY
$92.01 - $123.21 $1.37 Million - $1.84 Million
14,942 Added 24.19%
76,722 $7.42 Million
Q1 2018

May 09, 2018

SELL
$92.01 - $123.21 $1.37 Million - $1.84 Million
-14,942 Reduced 19.48%
61,780 $0
Q4 2017

Jan 24, 2018

SELL
$89.56 - $98.21 $2.95 Million - $3.23 Million
-32,893 Reduced 30.01%
76,722 $0
Q3 2017

Oct 30, 2017

SELL
$69.85 - $89.22 $210,458 - $268,819
-3,013 Reduced 2.68%
109,615 $9.74 Million
Q2 2017

Jun 03, 2019

SELL
N/A
-5,909 Reduced 4.98%
112,628 $8.17 Million
Q1 2017

Jun 03, 2019

BUY
N/A
15,273 Added 14.79%
118,537 $7.72 Million
Q4 2016

Jun 03, 2019

BUY
N/A
29,349 Added 39.71%
103,264 $6.47 Million
Q2 2016

Jun 03, 2019

BUY
N/A
64,347 Added 672.52%
73,915 $4.58 Million
Q1 2016

Jun 03, 2019

BUY
N/A
9,568
9,568 $767,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.